Association of the Leu72Met polymorphism of the ghrelin gene and ghrelin level with type 2 diabetes mellitus and obesity

被引：2
作者：
Nadida A. Gohar
Dina F. Elgayar
Ayat I. Hassan
Samar H. Aboulsoud
Mona A. Hegazy
机构：
[1] Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo
[2] Department of Clinical Pathology, National Institute of Diabetes and Endocrinology, Cairo University, Cairo
[3] Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo
[4] Giza, 45 Lebanon St., Mohandiseen
来源：
Comparative Clinical Pathology | 2012年 / 21卷 / 6期
关键词：
Diabetes; Genetic polymorphism; Ghrelin; Obesity; Polymerase chain reaction (PCR);
D O I：
10.1007/s00580-011-1318-0
中图分类号：
学科分类号：
摘要：
The aim of the study is to resolve the debated association between ghrelin level and polymorphism of ghrelin gene (Leu72Met) with obesity and type 2 diabetes mellitus. The present study was conducted on 30 diabetic middle-aged patients with normal body mass index (BMI) and 40 age-matched non-diabetic participants (20 with normal BMI and 20 obese). All participants were subjected to full medical history and examination, anthropometric measurements, and laboratory investigations which include complete lipid profile, fasting plasma glucose, glycated hemoglobin, fasting serum insulin and HOMA-IR was calculated, fasting plasma ghrelin level was determined using ELISA method, and the Leu72Met polymorphism of the ghrelin gene was screened using PCR-RFLP. The median level of fasting plasma ghrelin was higher in the diabetic group than those of the non-diabetic group (P = 0. 157). However, lower median fasting plasma ghrelin level was reported in the obese group compared to those with normal BMI, yet not statistically significant (P = 0. 289). In the present study, Leu72Met polymorphism was present in 13% of the diabetic subjects, 20% of the non-diabetic subjects with normal BMI, and in 30% of the obese non-diabetic participants. No statistically significant association was found between the ghrelin level and the Leu72Met polymorphism in preproghrelin gene with either obesity or type 2 diabetes mellitus. © 2011 Springer-Verlag London Limited.
引用
收藏
页码：1493 / 1499
页数：6
相关论文
共 43 条
  • [1] Diagnosis and classification of diabetes mellitus, Diabetes Care, 33, (2010)
  • [2] Barazzoni R., Zanetti M., Ferreiral, Relationships between desacylated and acylated ghrelin and insulin sensitivity in metabolic syndrome, J Clin Endocrinol Metab, 92, pp. 3935-3940, (2007)
  • [3] Berthold H.K., Giannakidou E., Krone W., Mantzoros C.S., Gouni-Berthold I., The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes, Clinica Chimica Acta, 399, pp. 112-116, (2009)
  • [4] Carlson J.J., Turpin A.A., Wiebke G., Hunt S.C., Pre- and post-prandial appetite hormone levels in normal weight and severely obese women, Nutr Metab (Lond), 11, 6, pp. 32-37, (2009)
  • [5] Castaneda T.R., Tong J., Datta R., Culler M., Tscop M.H., Ghrelin in the regulation of body weight and metabolism, Front Neuroendocrinol, 31, pp. 44-60, (2010)
  • [6] Chevenne D., Trivin F., Porquet D., Insulin assays and reference values, Diabetes Metab, 25, 6, pp. 459-476, (1999)
  • [7] Choi H.J., Cho Y.M., Moon M.K., Choi H.H., Shin H.D., Jang H.C., Kim S.Y., Lee H.K., Park K.S., Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans, J Clin Endocrinol Metab, 91, pp. 4657-4663, (2006)
  • [8] Dezaki K., Sone H., Yada T., Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis, Pharmacol Ther, 118, 2, pp. 239-249, (2008)
  • [9] Fossati P., Prencipel L., Estimation of triglycerides concentration in serum and plasma, Clin Chem, 28, pp. 2077-2080, (1982)
  • [10] Friedwald W.T., Levy R.I., Fredrickson D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge, Clin Chem, 18, pp. 499-502, (1972)
12345